Top Markets
#1 TENDIES TENDIES +60.89%
#2 Threshold Network Threshold Network +54.06%
#3 Cash Cat Cash Cat +21.98%
#4 OSK OSK +16.53%
#5 Kinetiq Kinetiq +16.42%
#6 Mubarak Mubarak +13.34%
#7 Maple Finance Maple Finance +13.30%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Magma Finance Magma Finance +12.08%
#10 Kite Kite +11.50%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rang in Aktien #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aktienkurs
$0.8799
Zuletzt synchronisiert: 2026-09-01
Marktkapitalisierung
$259.22M
Veränderung (1 Tag)
-7.85%
Veränderung (1 Jahr)
-14.57%
Land
US
Handel Invivyd, Inc. (IVVD)

Kategorie

Healthcare
Kursverlauf für Invivyd, Inc. (IVVD)
Höchster Schlusskurs: $0.85 am 2026-09-01

Niedrigster Schlusskurs: $27.68 am 2021-08-01
Kursverlauf der Aktie von Invivyd, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -37.40%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.65 37.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.27%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.50 513.89%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $763.69 9.05%
CH